Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.
By K. O'Brien, L. Wolfson, J. Watt, E. Henkle, Maria Deloria-Knoll, N. McCall, Ellen Lee, K. Mulholland, O. Levine, T. Cherian. The Lancet, 2009
2,425 citations recorded by the source corpus.
BACKGROUND Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and sepsis in children worldwide. However, many countries lack national estimates of disease burden. Effective interventions are available, including pneumococcal conjugate vaccine and case management. To support local and global policy decisions on pneumococcal disease prevention and treatment, we estimated country-specific incidence of serious cases and deaths in children younger than 5 years. METHODS We measured the burden of pneumococcal pneumonia by applying the proportion of pneumonia cases caused by S pneumoniae derived from efficacy estimates from vaccine trials to WHO country-specific estimates of all-cause pneumonia cases and deaths. We also estimated burden of meningitis and non-pneumonia, non-meningitis invasive disease using disease incidence and case-fatality data from a systematic literature review. When high-quality data were available from a country, these were used for national estimates. Otherwise, estimates were based on data from neighbouring countries with similar child mortality. Estimates were adjusted for HIV prevalence and access to care and, when applicable, use of vaccine against Haemophilus influenzae type b. FINDINGS In 2000, about 14.5 million episodes of serious pneumococcal disease (uncertainty range 11.1-18.0 million) were estimated to occur. Pneumococcal disease caused about 826,000 deaths (582,000-926,000) in children aged 1-59 months, of which 91,000 (63,000-102,000) were in HIV-positive and 735,000 (519,000-825,000) in HIV-negative children. Of the deaths in HIV-negative children, over 61% (449,000 [316,000-501,000]) occurred in ten African and Asian countries. INTERPRETATION S pneumoniae causes around 11% (8-12%) of all deaths in children aged 1-59 months (excluding pneumococcal deaths in HIV-positive children). Achievement of the UN Millennium Development Goal 4 for child mortality reduction can be accelerated by prevention and treatment of pneumococcal disease, especially in regions of the world with the greatest burden. FUNDING GAVI Alliance and the Vaccine Fund.
Subfields: Epidemiology, Microbiology
View Paper: https://www.semanticscholar.org/paper/1e6ca3f6a18509fd70cc41ccb5133e4c4480a177
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Bradley
- Samir S Shah
- C. Harrison
- C. Byington
- S. Kaplan
- M. Moore
- G. Mccracken
- E. Carter
Citations in the corpus
- The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (2011, background): “influenzae type b are among the most common causes of pediatric CAP worldwide [303, 304].”